Skip to main content
OpenTrials
Completed

NCT Number: NCT01963338

A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination

The aim of this study was to assess the acceptability and usability of a newly developed intradermal device in healthy adults

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Antwerp

Wilrijk, Antwerp, 2650, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy adults

Exclusion criteria

  • people who have regular experience with needle injections, e.g. diabetic patients
  • pregnant women

Treatment and study plan

Intradermal injection in the forearm (0,1cc NaCl 0,9%)

Device

This injection is conducted by the newly developed device.

Intradermal injection in the upper arm (0,1cc NaCl 0,9%)

Device

This injection is conducted by the newly developed device in the upper arm (deltoid region).

Intramuscular injection in the upper arm (0,5cc NaCl 0,9%)

Drug

This injection is conducted by needle and syringe in the upper arm (deltoid region).

Primary outcomes

  1. Acceptability (e.g. pain) of an injection with an intradermal vaccine delivery device compared to an intramuscular injection with syringe and needle

    Time frame: 1 day (directly after the injections)

    Each of the volunteers was asked to complete two questionnaires: first questionnaire surveyed demographic parameters, including gender, age, health care related job or education, number of vaccinations and blood samples taken during the last 5 years, second questionnaire surveyed the experience of ID and/or IM injection, such as anxiety, pain during injection and duration of injection. Also the perception of the participant towards injections into the forearm, which could be perceived as an unnatural site for vaccination, and perception towards the need to undress for IM vaccination, i.e. preparing the upper arm for injection, was asked. The Visual Analogue Scale (1=no agreement; 10=full agreement) was used to score the statements.

  2. Adverse events after an injection with an intradermal delivery device and/or intramuscular injection with syringe and needle

    Time frame: during 5 days after the injections

    Volunteers were asked to fill a daily electronic diary for 5 days after the injections. The diary surveyed the presence of local reactions (pain at injection site, redness, swelling, ecchymosis and hardening) and systemic adverse events (headache, malaise, chills, myalgia, arthralgia, weakness/fatigue and temperature). In case of local reactions, participants were asked to measure the size of the reaction (in mm). For this purpose, a transparent ruler was provided to the participants at the study day.

Secondary outcomes

  1. Usability (e.g. handling) of an injection with an intradermal vaccine delivery device compared to an intramuscular injection with syringe and needle

    Time frame: Within one day after administering the injections

    At the end of a study day, the nurses performing the injections received a questionnaire that assessed the usability of VAX-ID. The nurses were requested to rate the attractiveness, handling, solidity, safety and ease of use. Some questions assessed their experience relating to painful(ness), speed and injection sites. Also their thoughts on the usability by non-medical staff (with or without any manual) and on self-administration by patients were inquired.

    The Visual Analogue Scale (1=no agreement; 10=full agreement) was used to score the statements. An expert panel was organized in order to gather additional comments, remarks and proposed improvements on the use of the VAX-ID.

Sponsors and collaborators

Lead sponsor

Pierre Van Damme

Other

Registry information

Official study title

A Randomized Controlled Study to Assess the Acceptability and Usability of New Delivery Device for Intradermal Vaccination in Healthy Volunteers

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Oct 16, 2013
Registry last updated
Mar 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.